Search Results - "Verweij, S P"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Haemostatic differences between SARS-CoV-2 PCR-positive and negative patients at the time of hospital admission by de Laat, B, Traets, M J M, De Laat-Kremers, R W M, Verweij, S P, Ninivaggi, M, Jong, E, Huskens, D, Blok, B A, Remme, G C P, Miszta, A, Nijhuis, R H T, Herder, G J M, Fijnheer, R, Roest, M, Fiolet, A T L, Remijn, J A

    Published in PloS one (28-04-2022)
    “…Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with thrombosis. We conducted a…”
    Get full text
    Journal Article
  2. 2

    Lymphogranuloma venereum variant L2b-specific polymerase chain reaction: insertion used to close an epidemiological gap by Verweij, S.P., Catsburg, A., Ouburg, S., Lombardi, A., Heijmans, R., Dutly, F., Frei, R., Morré, S.A., Goldenberger, D.

    Published in Clinical microbiology and infection (01-11-2011)
    “…The management of the ongoing lymphogranuloma venereum epidemic in industrialized Western countries caused by Chlamydia trachomatis variant L2b still needs…”
    Get full text
    Journal Article
  3. 3

    Serogroup distribution of urogenital Chlamydia trachomatis in urban ethnic groups in The Netherlands by VERWEIJ, S. P., QUINT, K. D., BAX, C. J., VAN LEEUWEN, A. P., MUTSAERS, J. A. E. M., JANSEN, C. L., OOSTVOGEL, P. M., OUBURG, S., MORRÉ, S. A., PETERS, R. P. H.

    Published in Epidemiology and infection (01-02-2014)
    “…The prevalence of Chlamydia trachomatis varies between ethnic groups in The Netherlands. It is, however, unknown whether this is associated with specific…”
    Get full text
    Journal Article
  4. 4

    Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department by Nijhuis, R.H.T., Russcher, A., de Jong, G.J., Jong, E., Herder, G.J.M., Remijn, J.A., Verweij, S.P.

    Published in Journal of clinical virology (01-12-2020)
    “…•The prevalence of SARS-CoV-2 in blood from patients with COVID-19 was determined.•SARS-CoV-2 was found in 5.9 % of the tested patients.•Plasma should not be…”
    Get full text
    Journal Article
  5. 5

    Toll-Like Receptors (TLRs) Expression in Contracted Capsules Compared to Uncontracted Capsules by Bachour, Y., Ritt, M. J. P. F., Heijmans, R., Niessen, F. B., Verweij, S. P.

    Published in Aesthetic plastic surgery (01-08-2019)
    “…Introduction The etiology of capsular contracture after surgical implantation of breast implants remains unclear, but an important role is seen for the immune…”
    Get full text
    Journal Article
  6. 6

    Waddlia chondrophila and Chlamydia trachomatis antibodies in screening infertile women for tubal pathology by Verweij, S.P., Kebbi-Beghdadi, C., Land, J.A., Ouburg, S., Morré, S.A., Greub, G.

    Published in Microbes and infection (01-11-2015)
    “…Since Waddlia chondrophila is closely related to Chlamydia trachomatis, we hypothesise that W. chondrophila may also be associated with tubal factor…”
    Get full text
    Journal Article
  7. 7

    Chlamydia trachomatis infections and subfertility: opportunities to translate host pathogen genomic data into public health by Lal, J A, Malogajski, J, Verweij, S P, de Boer, P, Ambrosino, E, Brand, A, Ouburg, S, Morré, S A

    Published in Public health genomics (01-01-2013)
    “…Chlamydia trachomatis (CT) infections in women can result in tubal pathology (TP). Worldwide 10-15% of all couples are subfertile, meaning they did not get…”
    Get more information
    Journal Article
  8. 8

    Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in an STI population: performances of the Presto CT-NG assay, the Lightmix Kit 480 HT CT/NG and the COBAS Amplicor with urine specimens and urethral/cervicovaginal samples by Schuurs, T A, Verweij, S P, Weel, J F L, Ouburg, S, Morré, S A

    Published in BMJ open (01-01-2013)
    “…Objectives This study assessed the performances of the Presto CT-NG assay, the Lightmix Kit 480 HT CT/NG and the COBAS Amplicor for Chlamydia trachomatis and…”
    Get full text
    Journal Article
  9. 9

    Significantly higher serologic responses of Chlamydia trachomatis B group serovars versus C and I serogroups by Verweij, S P, Bax, C J, Quint, K D, Quint, W G V, van Leeuwen, A P, Peters, R P H, Oostvogel, P M, Mutsaers, J A, Dörr, P J, Pleijster, J, Ouburg, S, Morré, S A

    Published in Drugs of today (Barcelona, Spain : 1998) (01-11-2009)
    “…Chlamydia trachomatis serovars are divided into three serogroups, namely serogroup B, serogroup I (Intermediate) and serogroup C, and subsequently into 19…”
    Get full text
    Journal Article
  10. 10

    SHORT REPORT: Serogroup distribution of urogenital Chlamydia trachomatis in urban ethnic groups in The Netherlands by VERWEIJ, S. P., QUINT, K. D., BAX, C. J., VAN LEEUWEN, A. P., MUTSAERS, J. A. E. M., JANSEN, C. L., OOSTVOGEL, P. M., OUBURG, S., MORRÉ, S. A., PETERS, R. P. H.

    Published in Epidemiology and infection (01-02-2014)
    “…The prevalence of Chlamydia trachomatis varies between ethnic groups in The Netherlands. It is, however, unknown whether this is associated with specific…”
    Get full text
    Journal Article